Topical Corticosteroid Phobia Among Healthcare Professionals Using the TOPICOP Score

Acta Derm Venereol. 2019 Oct 1;99(11):1004-1008. doi: 10.2340/00015555-3220.

Abstract

Corticophobia is a major problem in adherence to therapy. This study examined corticophobia among healthcare professionals using the Topical Corticosteroid Phobia (TOPICOP) questionnaire. The TOPICOP questionnaire was adapted for use with professionals (TOPICOP-P). Four groups of professionals: pharmacists, paediatricians, general practitioners and dermatologists were observed. The mean global TOPICOP score was 41.9 ± 14.9%. Pharmacists had the highest scores for corticophobia: a global score of 48.5 ± 13.9%, followed by general practitioners, 46.0 ± 13.5%, paediatricians 39.7 ± 14.5%, and dermatologists 32.3 ± 12.1%. Overall, there was a statistically significant difference in the mean score between the 4 groups (p < 0.05). In conclusion, there is prominent corticophobia among healthcare professionals, especially among pharmacists and general practitioners, which is probably based on insufficient knowledge of topical corticosteroids. In order to improve patient compliance, re-education of healthcare providers is suggested.

Keywords: corticophobia; dermatologist; general practitioner; paediatrician; pharmacist; atopic dermatitis.

MeSH terms

  • Administration, Topical
  • Adrenal Cortex Hormones / administration & dosage*
  • Adrenal Cortex Hormones / adverse effects*
  • Adult
  • Attitude of Health Personnel*
  • Dermatologists / psychology
  • Female
  • General Practitioners / psychology
  • Health Knowledge, Attitudes, Practice*
  • Health Personnel / education
  • Health Personnel / psychology*
  • Humans
  • Inservice Training
  • Male
  • Medication Adherence
  • Pediatricians / psychology
  • Pharmacists / psychology
  • Phobic Disorders / psychology*
  • Practice Patterns, Physicians'*
  • Prospective Studies
  • Risk Assessment
  • Surveys and Questionnaires

Substances

  • Adrenal Cortex Hormones